Idsk -- Proton pump inhibitors are appropriate in patients who have multiple risk factors for gastrointestinal bleeding and who require antiplatelet therapy, according to an updated expert consensus report published online Nov. 8 simultaneously by the American College of Cardiology Foundation, the American College of Gastroenterology, and the American Heart Association.
